Keith Speights artical! | NVAX Message Board Posts


NVAX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  145321 of 198556  at  10/14/2021 8:52:43 AM  by

BillyT


 In response to msg 145320 by  arkenfisher
view thread

Re: Keith Speights artical!

I wish Speights would tell us how he figured on only $5.5B in sales for 2022. They have orders locked up for about 1.5B doses. That seems like an awfully low revenue estimate. The big question on valuation is going to be based on likelihood of a continued revenue stream. I typically estimate market value a 3x sales assuming not much recurring revenue. If COVID requires annual boosters, then I can see upping this to 5-6x sales.

Let's just get the first approval and go from there. The the rest will take care of itself.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 5  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
145322 Re: Keith Speights artical! andrew0329 0 10/14/2021 8:54:45 AM
145341 Re: Keith Speights artical! redplate 0 10/14/2021 11:10:08 AM




Financial Market Data provided by
.
Loading...